VANCOUVER, B.C. – Feb. 22, 2018 (GLOBE NEWSWIRE) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) [...]
NeutriSci is a global leader in the innovation, production,
and formulation of clinically proven products.
PERFECTED BY SCIENCE.
NeutriSci International Inc. (TSX.NU) is a Canadian public corporation specializing in the marketing, development and distribution of proprietary nutraceuticals. NeutriSci develops effective marketing and branding strategies for nutraceutical partners around the world. Established in 2009, NeutriSci has focused on the market development of several breakthrough nutraceutical products.
SUBSCRIBE TO OUR MAILING LIST!
Never miss an update or press release from NeutriSci International! Subscribe to our mailing list today and be the first to know when we publish updates and new press releases.
NeutriSci International complies with Canada’s Anti-Spam Legislation (CASL) and will not spam or sell your information to third party groups.
LATEST PRESS RELEASE
IN THE NEWS
From Nutraceuticals to Cannabinoid Pharmaceuticals
(NetworkNewsWire, Jan 28, 2018)
Cannabis MOU Develops Better Drug Delivery System
(Stockhouse, Jan 09, 2018)
NeutriSci Enters Research and Development MOU with Scientus Pharma Inc
(NetworkNewsWire, Jan 08, 2018)
NeutriSci, Scientus Pharma in R&D Pact for Medical Cannabinoid
(BioTuesdays, Jan 08, 2018)